Allylamides useful in the treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/47 (2006.01) A61K 31/195 (2006.01) A61K 31/401 (2006.01) A61K 31/495 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2462875

Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula (I) where R1, R2, R3, B, Jl, J2, X and Z are as defined herein.

L'invention concerne des méthodes permettant de traiter la maladie d'Alzheimer et d'autres maladies, et/ou d'inhiber l'enzyme bêta-sécrétase, et/ou d'inhiber le dépôt de peptide bêta A chez un mammifère, par l'utilisation de composés de formule (I), dans laquelle R¿1?, R¿2?, R¿3?, B, J?1¿, J?2¿, X et Z sont tels que définis dans la description.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Allylamides useful in the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Allylamides useful in the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allylamides useful in the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1523760

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.